Methyl 2,3,6-Tri-O-benzoyl-alpha-D-galactopyranoside>98.0%(HPLC)25g

1,6-Dibromo-3,8-diisopropylpyrene, 95.0%, 250mg

Copper(II) acetate monohydrate, min. 99%, pa, ACS, 50 g, plastic packaging.

5-Hydroxy-2-methylbenzoic acid, 97.0%, 5g

1-Bromo-2-chloro-6-iodobenzene, 95.0%, 5g

(E)-6,6'-(ethene-1,2-diyl)bis(3-hydrazinylbenzenesulfonic acid), 98%, 1g

{2-[3-(methoxymethyl)-1,2,4-oxadiazol-5-yl]ethyl}amine hydrochloride, 95.0%, 100mg

3-(4-Bromophenyl)-5-methyl-1,2,4-oxadiazole, 95.0%, 5g

2-(Benzyloxy)-4-fluorobenzoic acid, 95+%, 1g

(1S,2S)-(-)-1,2-DIAMINOCYCLOHEXANE-N,N'-BIS(2'-DIPHENYLPHOSPHINOBENZOYL), 97%, 250mg

(11bR)-N,N-Bis((1S)-1-phenylethyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 98.0%, 1g

2,5-Difluoro-4-nitrobenzonitrile, 95.0%, 250mg

1-Naphthylmalononitrile>95.0%(HPLC)1g